Gene Mutations in Lung Cancer: Promising Predictive Factors for the Success of Molecular Therapy

Gefitinib and erlotinib are two new treatments for advanced lung cancer. Gene mutations in the cancer may help predict which patients will respond to these treatments

Detalles Bibliográficos
Autores principales: Inoue, Akira, Nukiwa, Toshihiro
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2005
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545205/
https://www.ncbi.nlm.nih.gov/pubmed/15696203
http://dx.doi.org/10.1371/journal.pmed.0020013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545205/
https://www.ncbi.nlm.nih.gov/pubmed/15696203
http://dx.doi.org/10.1371/journal.pmed.0020013

Ejemplares similares